These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2836153)

  • 41. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from he kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 5. Preclinical evaluation of the urinary NAG activity and its fluctuations in kidney and liver diseases and diabetes mellitus].
    Kin K; Akiyoshi R; Ohashi M; Nihonyanagi Y
    Rinsho Byori; 1983 Sep; Spec No 56():102-10. PubMed ID: 6663751
    [No Abstract]   [Full Text] [Related]  

  • 42. [N-acetyl-beta-D-glucosaminidase and diurnal excretion of hydroxyproline in chronic viral hepatitis].
    Laskus T; Gruszecka H; Lupa E; Cianciara J; Babiuch L
    Wiad Lek; 1992 Apr; 45(7-8):255-8. PubMed ID: 1462584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of nifedipine on hepatic hyaluronic acid, hydroxyproline and glucosaminidase contents in rats with liver fibrosis].
    Che J; Lu H; Li D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Feb; 16(1):35-8. PubMed ID: 7954965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
    Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
    Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activity of isoenzyme A and N-acetyl-beta-glucosaminidase in fibrotic liver tissue.
    Schneider M; Pott G; Müller KM; Gerlach U
    Hepatogastroenterology; 1980 Dec; 27(6):465-7. PubMed ID: 7203379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Study of N-acetyl-beta-D-glucosaminidase (NAG) activity in the human semen].
    Yoshida K; Nakame Y; Takahashi T; Saito H; Kihara K
    Hinyokika Kiyo; 1987 Mar; 33(3):391-5. PubMed ID: 3618406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
    Lieber CS; Weiss DG; Paronetto F;
    Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation.
    Hei ZQ; Li XY; Shen N; Pang HY; Zhou SL; Guan JQ
    Chin Med J (Engl); 2008 Jul; 121(14):1251-6. PubMed ID: 18713542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
    Kozłowska J; Łoch T; Jabłońska J; Cianciara J
    Przegl Epidemiol; 2001; 55(4):451-8. PubMed ID: 11921731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation.
    Harada N; Soejima Y; Taketomi A; Yoshizumi T; Ikegami T; Yamashita Y; Itoh S; Kuroda Y; Maehara Y
    Transplantation; 2008 Jan; 85(1):69-74. PubMed ID: 18192914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activity of procollagen-prolyl-hydroxylase and N-acetyl-beta-glucosaminidase in liver biopsies from patients with chronic liver diseases.
    Pott G; Eberhardt G; Gerlach U
    Klin Wochenschr; 1979 Jun; 57(11):587-8. PubMed ID: 459373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Collagen peptidase and type III procollagen peptide serum levels in chronic liver diseases.
    Müller A; Krombholz B; Pott G; Machnik G; Vollandt R; Reinhardt M; Jorke D
    Clin Chim Acta; 1991 Feb; 197(1):59-66. PubMed ID: 1646085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Monamine oxidase (MAO)].
    Nakano H; Takamatsu S; Yamamoto Y
    Nihon Rinsho; 1995 May; 53(5):1168-72. PubMed ID: 7602774
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on serum n-acetyl-beta-d-glucosaminidase in pregnancy.
    Nobutani J; Hirosawa T; Nobutani J; Torigoe T
    Acta Obstet Gynaecol Jpn; 1975 Jan; 22(1):1-5. PubMed ID: 1224944
    [No Abstract]   [Full Text] [Related]  

  • 57. [N-acetyl-beta-D-glucosaminidase in jaundice syndrome].
    Sánchez Rodríguez A; Criado Jiménez M; Pérez Sandoval D; Rico Sánchez J; Hueso Pérez J; Sánchez Fuentes D; Mejía Molina P; de Portugal Alvarez J
    An Med Interna; 1989 May; 6(5):239-43. PubMed ID: 2491536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [What is reliable in therapy of liver fibrosis?].
    Högemann B
    Z Gastroenterol; 1992 May; 30(5):333-6. PubMed ID: 1321534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experimental aspects of hepatic fibrosis.
    Stern R
    Prog Liver Dis; 1979; 6():173-85. PubMed ID: 232279
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effects of insulin on maltase and N-acetyl-beta-D-glucosaminidase (NAG) activities of serum and kidney in experimental diabetic rats].
    Iizuka Y; Sakurai E; Hikichi N; Niwa H
    Nihon Yakurigaku Zasshi; 1989 Aug; 94(2):129-35. PubMed ID: 2530141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.